Low level in CSF, serum, and plasma of AD, and serum and plasma of MCI. Potential target of the 3′ UTR of APP.Negative correlation between levels of miR-193b and Aβ42 in the CSF of patients with DAT (r = −0.442), and control group (r = −0.503). Here, APP is linked to Alzheimer disease.